Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 10.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 10.30% | |||
| Cost of Revenue | 0.00% | 82.35% | |||
| Gross Profit | 0.00% | 8.51% | |||
| SG&A Expenses | 0.00% | 0.51% | |||
| Depreciation & Amortization | 0.00% | -31.03% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 0.91% | |||
| Operating Income | 0.00% | 43.10% | |||
| Income Before Tax | 0.00% | 57.20% | |||
| Income Tax Expenses | 0.00% | 64.80% | |||
| Earnings from Continuing Operations | 0.00% | 55.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 55.76% | |||
| EBIT | 0.00% | 43.10% | |||
| EBITDA | 0.00% | 28.93% | |||
| EPS Basic | 0.00% | 55.56% | |||
| Normalized Basic EPS | 0.00% | 56.14% | |||
| EPS Diluted | 0.00% | 55.56% | |||
| Normalized Diluted EPS | 0.00% | 56.14% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||